Navigation Links
Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial
Date:3/18/2009

assisTek, the Leader in Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for Clinical Trials announced that it has been awarded a contract to use their state-of-the-art smart phone technology to collect data from patients at home on electronic diaries in an upcoming large multi-national clinical trial.

Scottsdale, AZ (PRWEB) March 18, 2009 -- assisTek, the Leader in Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for Clinical Trials announced that it has been awarded a contract to use their state-of-the-art smart phone technology to collect data from patients at home on electronic diaries in an upcoming large multi-national clinical trial.

The smart phone chosen for the trial will be an HTC Fuze, which looks similar to Apple iPhone. It provides significant advantages over past electronic diary solutions based on Palm technology.

Palm-based devices require patients to install, implement, and use a modem interface in their home on a daily basis to transfer the data from the device to a central data repository. Because patients participating in clinical trials often have significant other challenges, this requirement can be difficult and time consuming for all clinical trial participants -- the patients, clinicians, and technology vendors.

Benefits:

  • assisTek's smart phone product, the MobilePRO eliminates much of the work and hassle associated with Palm devices.
  • The smart phone transfers data automatically through cell phone networks using the SIM card inside the phone.
  • This technological breakthrough will save countless hours of work in clinical trial data collection.

"We are very proud to lead the industry in providing innovative electronic diary solutions to collect data from patients in clinical trials," said Joy Hebert, Chief Executive Officer of assisTek. "We introduced the collection of patient reported outcomes on Apple iPhones and internet platforms last year, and are proud to now deliver this new breakthrough product this year."

Not only does this technology significantly reduce the work and hassle factor in collecting data from patients, it is also a beautiful product. It includes striking colors and photos not available in the older technologies offered by other vendors.

"We look forward to providing our clinical trial participants with this capability. Participating in a clinical trial is a significant time commitment for patients, stated Dr. Temitayo Ajayi, Medical Director for PTC Therapeutics. "We believe it is beneficial to utilize state of the art technology, such as the assisTek Smart Phones to minimize the reporting burden and potentially increase compliance utilizing accessible technologies."

For more information about assisTek's ePRO systems or to schedule a free no-obligation demonstration, contact assisTek.

About assisTek
assisTek is the global leader in ePRO systems and has revolutionized the process of collecting patient-reported outcomes in clinical trials by helping sites collect the data electronically through innovation, using touch-screens tablets, internet, Apple iPhones, and other smart phones.

The assisTek team has more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents. Visit assisTek online.

# # #

Read the full story at http://www.prweb.com/releases/assistek/epro-smartphone/prweb2244074.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. Delta Dental of Illinois Introduces Smile Smart For Your Health
4. Toddler Study Proves Humans Outsmart Apes
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. Smart insulin nanostructures pass feasibility test, UT study reports
7. New Oral-B(R) Triumph(TM) With SmartGuide(TM) is the First Power Toothbrush With a Wireless Display
8. Pasta Gets Smarter - and Healthier
9. Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter
10. Oridion Introduces New Smart Capnography System for Improved Patient Safety
11. SafeSmart, Inc. Presents SafetyTies to Sixth Annual MedAssets Technology Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial
(Date:4/28/2016)... VATICAN CITY (PRWEB) , ... April 28, 2016 ... ... medicine is on the world stage this week. A group of researchers and ... Conference on the Progress of Regenerative Medicine and Its Cultural Impact ” and ...
(Date:4/28/2016)... ... 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has ... be held at the University of Montana on April 28-May 1. Varize will compete ... , In order to qualify, Varize needed to place top seven all-around in her ...
(Date:4/28/2016)... ... 2016 , ... Cosmetic Town, an online plastic surgery community, announces the relaunch ... recently revamped and upgraded to allow even more interaction between doctors and patients as ... According to the senior editor of Cosmetic Town, “We are excited that our ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
(Date:4/28/2016)... ... ... One way to ignore solid evidence is to dismiss research because, “it ... baby out with the bathwater when we ignore all studies because some are fatally ... making better use of education policy research. , “When readers heed basic cautions, research ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... 2016 TapImmune,Inc. (TPIV), a ... and gene-based immunotherapeutics and vaccines for the treatment of cancer ... the 3rd Annual Growth Capital Expo to be ... at Caesars Palace in Las Vegas, Nevada.  The Company ... 4 th by Dr. John N. Bonfiglio ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: